|
Phase I Study of Noni in Cancer Patients Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Phase I Study of Noni in Cancer Patients conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Phase I Study of Noni in Cancer Patients Clinical research trials and Phase I Study of Noni in Cancer Patients health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Phase I Study of Noni in Cancer Patients. Phase I Study of Noni in Cancer Patients Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Phase I Study of Noni in Cancer Patients clinical trial. Subjects frequently get the best healthcare possible for their Phase I Study of Noni in Cancer Patients condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Phase I Study of Noni in Cancer Patients  Phase I Study of Noni in Cancer Patients
Phase I Study of Noni in Cancer Patients
For Condition: Neoplasm Metastasis,Neoplasms
Status: Recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: The purpose of this Phase 1 study is to: 1. determine the maximum tolerated dose of capsules containing 500mg of freeze dried noni fruit extract, 2. define toxicities associated with the ingestion of noni, 3. collect preliminary information on the efficacy of noni in respect to anti-tumor and symptom control properties to help select specific patients for subsequent Phase 2 studies, 4. identify chemical constituents of the extract that can be used to characterize the bioavailability and pharmacokinetics of noni food supplement.
Details: This Phase I study of noni in cancer patients represents a first step in the systematic study of Complementary and Alternative Medicine (CAM) practices that draw on Asian and Pacific Island cultural traditions of healing to control cancer and its related symptoms. Noni, extracted from Morinda citifolia or the Indian mulberry plant, is included in the traditional pharmacopoeias of Native Hawaiians, other Pacific Islanders and Asian populations, and has been used to treat various diseases for hundreds of years. It is now commonly taken by cancer patients based on purported usefulness in the disease although there is little scientific evidence to either support or refute these claims. A large marketing enterprise and at least eleven different suppliers supports the food supplement's popularity. The broad long range objectives which this study will initiate are to define the usefulness of noni extracts for cancer patients. The hypothesis to be tested is that noni at a specified dosing provides cancer patients with a sufficient benefit to toxicity profile to be useful as a therapeutic. Specific aims of this study are: 1. Determine the maximum tolerated dose of capsules containing 500mg of freeze-dried noni fruit extract. 2. Define toxicities associated with the ingestion of noni. 3. Collect preliminary information on the efficacy of noni in respect to anti-tumor and symptom control properties to help select specific patients for subsequent Phase II studies. 4. Identify chemical constituents of the extract that can be used to characterize the bioavailability and pharmacokinetics of noni food supplement.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients must: - Have a pathologically or cytologically verified diagnosis of cancer and evidence of disease for which no standard treatment is available; - Be ambulatory, capable of self care, and up and about more than 50% of waking hours; - Have completed all other cancer treatments at least four weeks previously; - Have been on any medications considered by their physician to be essential to their health (e.g. lipid lowering, antidiabetic , antihypertensive) at consistent dosing at least four weeks prior to starting noni; - Agree to take no other CAM treatments while taking noni and agree to keep a diary, recording all medications taken daily, including all non prescription products and to record the time that noni is taken.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
BrianIssell, Principal Investigator, University of Hawaii
University of Hawaii, Cancer Research Center *Recruiting*
Honolulu, Hawaii, 96813
United States
Recruiting
Additional Information:
Study ID Numbers: 1 R21 AT00896-01;
Study Start Date: November 2001
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033878
Other Neoplasm Metastasis Studies:
1. BMS-247550 to Treat Children with Solid Tumors
2. A Phase II study of carboplatin plus irinotecan versus irinotecan in children with refractory solid tumors
3. Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
4. Collection of Blood, Bone Marrow, Tumor or Tissue Samples
5. Phase I Study of HeFi-1 to Treat Cancers with CD30 Protein
Related Studies:
Other Neoplasm Metastasis Clinical Trials
Other Hawaii Clinical Trials
Other Honolulu Clinical Trials
Phase I Study of Noni in Cancer Patients
|
|
|
|
|
|
|
|
